B
BiO2 Medical
Leading commercial-stage developer of innovative vascular devices
About BiO2 Medical
BiO2 Medical, Inc. operates as a commercial-stage medical device company, focusing on developing vascular devices to address unmet clinical needs. Founded in December 2006 by Dr. Luis F. Angel, Christopher E. Banas, and Dr. Paul Castella, the company established its headquarters in San Antonio, Texas, with research, development, and manufacturing facilities in Golden, Colorado. The company's business revolves around the design, manufacturing, and commercialization of its flagship product, the Angel® Catheter. This device is sold to hospitals and medical centers for use with critically ill patients at high risk for pulmonary embolism (PE).
The company's primary product, the Angel® Catheter, is a combination of a central venous catheter (CVC) and an Inferior Vena Cava (IVC) filter. Invented by co-founder Dr. Luis F. Angel, an Associate Professor of Pulmonary and Critical Care Medicine, the device is designed to provide venous access while simultaneously protecting against PE by trapping blood clots. A key feature is that the filter is permanently attached to the catheter, which is designed to ensure its retrieval once it is no longer needed, mitigating risks associated with traditional IVC filters like migration and fracture. The Angel® Catheter is designed for bedside placement without the need for fluoroscopic guidance, streamlining the procedure for intensive care unit (ICU) patients. This approach provides immediate protection for patients for whom anticoagulant therapies may be contraindicated.
BiO2 Medical's history includes several significant funding rounds to support product development and commercialization. The company completed a $13.7M Series B round in March 2012 and secured $12M in a Series C round in September 2012. These funds were crucial for achieving CE Mark approval in Europe in 2012 and advancing through the FDA regulatory process in the U.S. A pivotal milestone was reached in August 2016 when the Angel® Catheter received 510(k) clearance from the FDA, notably including a first-ever prophylactic indication for a device to prevent PE. Subsequently, in August 2018, the Angel Catheter technology and associated intellectual property were acquired by Mermaid Medical Group, a Danish provider of medical devices, which took over supporting the existing customer base with plans for global expansion.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Mar 2017 | $1.5M | — | Undisclosed | — |
| DEBT✓Debt | Aug 2016 | $3M | — | Oxford Finance | — |
Growth signals
Latest recorded traffic for BiO2 Medical is 200 monthly website visits, up 66.7% over the last three months. BiO2 Medical's team grew 18.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
BiO2 Medical in the San Antonio ecosystem
The BiO2 Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- PCPasadera Capital
- TFTargeted Technology Fund
Texas Economic Development Corporation
Series B and later2 investors entered at this stage
Remeditex Ventures
Oxford Finance
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BiO2 Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BiO2 Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









